Structurally modified bisphosphonate with improved activity and oral bioavailability: ISA-13-1 Nov. 4, 1999
SB and NPS disclose calcilytics arising from joint research program; collaboration continues Nov. 3, 1999
Two compounds resulting from Ligand-Glaxo Wellcome collaboration advance through the pipeline Oct. 29, 1999
Positive phase Ib results reported for Cerus's red blood cell pathogen inactivation system Oct. 29, 1999
RSS